Location History:
- Kawasaki, JP (2017 - 2019)
- Kanagawa, JP (2022)
Company Filing History:
3 out of 14 
2 out of 272 
1 out of 441 
Years Active: 2017-2022
Title: Innovations by Yoshihisa Yamano
Introduction
Yoshihisa Yamano is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of HTLV-1-associated myelopathy. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Yamano's latest patents include a pharmaceutical composition used for the treatment of HTLV-1-associated myelopathy. This invention provides a pharmaceutical composition containing an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor, and an EZH1/2 dual inhibitor as an active ingredient. Another patent focuses on a therapeutic method and medicament for HTLV-1-associated myelopathy, aiming to provide a new therapeutic method and agent that differ from known treatments. This method is characterized by reducing HTLV-1 virus-infected cells using an anti-human CC-chemokine receptor 4 (CCR4) antibody.
Career Highlights
Yamano has worked with esteemed institutions such as St. Marianna University School of Medicine and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Yamano has collaborated with notable colleagues, including Natsumi Ueda and Kazushi Araki. Their combined efforts have further advanced research in the field of HTLV-1-associated myelopathy.
Conclusion
Yoshihisa Yamano's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for patients affected by HTLV-1-associated myelopathy. His work continues to pave the way for future advancements in this critical area of medicine.